Annals of Internal Medicine
2 June 2020Volume 172, Issue 11
Ideas and Opinions
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
Jinoos Yazdany, MD, MPH and Alfred H.J. Kim, MD, PhD
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for COVID-19. The authors of this commentary provide guidance for clinical decision making for patients with COVID-19 as well as for patients with rheumatologic conditions, such as systemic lupus erythematosus and rheumatoid arthritis.